3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
6
Colorectal Neoplasms
5
Neoplasms
4
Malnutrition
3
Lung Neoplasms
3
Diarrhea
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Mucositis
2
Inflammation
2
Enteritis
2
Chalazion
2
Carcinoma, Hepatocellular
2
Thyroid Neoplasms
1
Squamous Intraepithelial Lesions
1
Smoldering Multiple Myeloma
1
Radiation Injuries
1
Psychological Well-Being
1
Psoriasis Vulgaris
1
Polycystic Ovary Syndrome
1
Periampullary Carcinoma Nos
1
Pelvic Neoplasms
1
Pelvic Inflammatory Disease
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Neoplasms, Second Primary
1
Muscle Invasive Bladder Cancer (MIBC)
1
Multiple Myeloma
1
Motor Activity
1
Monoclonal Gammopathy of Undetermined Significance
1
Interventions
Metformin
149
Clomiphene
51
Letrozole
39
Inositol
35
Folic Acid
18
Exercise
17
Progesterone
15
Ethinyl Estradiol
13
Chorionic Gonadotropin
13
Caloric Restriction
13
drospirenone and ethinyl estradiol combination
12
Estradiol
12
Contraceptives, Oral
11
cetrorelix
10
Pioglitazone
10
High-Intensity Interval Training
10
Tablets
9
Spironolactone
9
Cholecalciferol
9
Triptorelin Pamoate
8
Diet
8
Vitamin D
7
Thioctic Acid
7
Menotropins
7
Liraglutide
7
Acupuncture Therapy
7
drospirenone
6
Ovidrel
6
Gonadotropins
6
Flutamide
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Polycystic Ovary Syndrome
×
Probiotics
×
Clear all
NCT04593459
2024-03-22
ProPCO-RCT
Medical University of Graz
Phase 4
Completed
112 enrolled